These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 6299522

  • 1. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
    Horowitz AD, Fujiki H, Weinstein IB, Jeffrey A, Okin E, Moore RE, Sugimura T.
    Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
    [Abstract] [Full Text] [Related]

  • 2. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
    Greenebaum E, Nicolaides M, Eisinger M, Vogel RH, Weinstein IB.
    J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
    [Abstract] [Full Text] [Related]

  • 3. Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin.
    Eliasson L, Kallin B, Patarroyo M, Klein G, Fujiki H, Sugimura T.
    Int J Cancer; 1983 Jan 15; 31(1):7-11. PubMed ID: 6299973
    [Abstract] [Full Text] [Related]

  • 4. Effects of teleocidin and the phorbol ester tumor promoters on cell transformation, differentiation, and phospholipid metabolism.
    Fisher PB, Miranda AF, Mufson RA, Weinstein LS, Fujiki H, Sugimura T, Weinstein IB.
    Cancer Res; 1982 Jul 15; 42(7):2829-35. PubMed ID: 6805947
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
    Weinstein IB, Arcoleo J, Backer J, Jeffrey A, Hsiao WL, Gattoni-Celli S, Kirschmeier P, Okin E.
    Princess Takamatsu Symp; 1983 Jul 15; 14():59-74. PubMed ID: 6097583
    [Abstract] [Full Text] [Related]

  • 6. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH, Gindhart TD, Hegamyer GA, Blumberg PM, Delclos KB, Magun BE, Lockyer J.
    Cancer Res; 1982 Aug 15; 42(8):3093-7. PubMed ID: 6284358
    [Abstract] [Full Text] [Related]

  • 7. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
    Jeng AY, Lichti U, Strickland JE, Blumberg PM.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5714-21. PubMed ID: 3931907
    [Abstract] [Full Text] [Related]

  • 8. Bromine residue at hydrophilic region influences biological activity of aplysiatoxin, a tumor promoter.
    Shimomura K, Mullinix MG, Kakunaga T, Fujiki H, Sugimura T.
    Science; 1983 Dec 16; 222(4629):1242-4. PubMed ID: 6316505
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity studies of aplysiatoxin-type tumor promoters.
    Moore RE.
    Princess Takamatsu Symp; 1983 Dec 16; 14():49-57. PubMed ID: 6243065
    [Abstract] [Full Text] [Related]

  • 10. The third class of new tumor promoters, polyacetates (debromoaplysiatoxin and aplysiatoxin), can differentiate biological actions relevant to tumor promoters.
    Fujiki H, Suganuma M, Nakayasu M, Hoshino H, Moore RE, Sugimura T.
    Gan; 1982 Jun 16; 73(3):495-7. PubMed ID: 7129014
    [Abstract] [Full Text] [Related]

  • 11. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors.
    Umezawa K, Weinstein IB, Horowitz A, Fujiki H, Matsushima T, Sugimura T.
    Nature; 1981 Apr 02; 290(5805):411-3. PubMed ID: 6261139
    [Abstract] [Full Text] [Related]

  • 12. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
    Blumberg PM, Delclos KB, Dunphy WG, Jaken S.
    Carcinog Compr Surv; 1982 Apr 02; 7():519-35. PubMed ID: 7039833
    [Abstract] [Full Text] [Related]

  • 13. Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates.
    Hiwasa T, Fujiki H, Sugimura T, Sakiyama S.
    Cancer Res; 1983 Dec 02; 43(12 Pt 1):5951-5. PubMed ID: 6416671
    [Abstract] [Full Text] [Related]

  • 14. Effect of cellular phospholipid modification on phorbol diester binding.
    Cabot MC.
    Cancer Res; 1983 Sep 02; 43(9):4233-8. PubMed ID: 6307508
    [Abstract] [Full Text] [Related]

  • 15. Promoter-induced cellular responses closely correlated with the enhancement of cell transformation.
    Kakunaga T, Hirakawa T, Shimomura K, Sugimura T.
    Princess Takamatsu Symp; 1983 Sep 02; 14():303-13. PubMed ID: 6097582
    [Abstract] [Full Text] [Related]

  • 16. Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells.
    Jaken S, Tashjian AH, Blumberg PM.
    Cancer Res; 1981 Dec 02; 41(12 Pt 1):4956-60. PubMed ID: 6272986
    [Abstract] [Full Text] [Related]

  • 17. Tumor promoter binding to rat mammary cell cultures: role of receptors in the inhibition of dome formation.
    Sonnenberg A, Dulbecco R, Okada S.
    Cancer Res; 1983 Mar 02; 43(3):1059-65. PubMed ID: 6297718
    [Abstract] [Full Text] [Related]

  • 18. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy.
    Jaken S, Shupnik MA, Blumberg PM, Tashjian AH.
    Cancer Res; 1983 Jan 02; 43(1):11-4. PubMed ID: 6600158
    [Abstract] [Full Text] [Related]

  • 19. Solubilization, purification, and reconstitution of a phorbol ester receptor from the particulate protein fraction of mouse brain.
    Ashendel CL, Staller JM, Boutwell RK.
    Cancer Res; 1983 Sep 02; 43(9):4327-32. PubMed ID: 6307511
    [Abstract] [Full Text] [Related]

  • 20. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
    Friedman B, Frackelton AR, Ross AH, Connors JM, Fujiki H, Sugimura T, Rosner MR.
    Proc Natl Acad Sci U S A; 1984 May 02; 81(10):3034-8. PubMed ID: 6328489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.